| 000 | 01611 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250514042734.0 | ||
| 264 | 0 | _c20030331 | |
| 008 | 200303s 0 0 eng d | ||
| 022 | _a1520-7552 | ||
| 024 | 7 |
_a10.1002/dmrr.299 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRen, Jun | |
| 245 | 0 | 0 |
_aalpha2-Heremans Schmid glycoprotein, a putative inhibitor of tyrosine kinase, prevents glucose toxicity associated with cardiomyocyte dysfunction. _h[electronic resource] |
| 260 |
_bDiabetes/metabolism research and reviews _c |
||
| 300 |
_a305-10 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBlood Proteins _xpharmacology |
| 650 | 0 | 4 |
_aCardiomyopathies _xphysiopathology |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 |
_aDiabetic Angiopathies _xphysiopathology |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aGlucose _xtoxicity |
| 650 | 0 | 4 |
_aHeart _xdrug effects |
| 650 | 0 | 4 | _aHeart Ventricles |
| 650 | 0 | 4 |
_aInsulin _xpharmacology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMuscle Cells _xdrug effects |
| 650 | 0 | 4 |
_aMyocardial Contraction _xdrug effects |
| 650 | 0 | 4 |
_aPhosphotyrosine _xmetabolism |
| 650 | 0 | 4 |
_aProtein-Tyrosine Kinases _xantagonists & inhibitors |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 | _aalpha-2-HS-Glycoprotein |
| 700 | 1 | _aDavidoff, Amy J | |
| 773 | 0 |
_tDiabetes/metabolism research and reviews _gvol. 18 _gno. 4 _gp. 305-10 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/dmrr.299 _zAvailable from publisher's website |
| 999 |
_c12085166 _d12085166 |
||